Dr. Ruoxi Zhang | Cardiology | Best Researcher Award

Dr. Ruoxi Zhang, Harbin Medical University, China.

Dr. Ruoxi Zhang is a distinguished physician and researcher specializing in cardiovascular medicine. He earned his doctorate from Harbin Medical University and has over a decade of clinical experience at renowned institutions, including The Second Affiliated Hospital of Harbin Medical University and Suzhou Kowloon Hospital. As a guest editor for Frontiers in Medicine and Frontiers in Cardiovascular Medicine, he has contributed to advancing medical research. His extensive publications focus on artificial intelligence in cardiology, interventional techniques, and diagnostic innovations. Dr. Zhang’s dedication to medical science and patient care underscores his significant contributions to the field of cardiovascular research.

Author Profile

Suitability for Best Researcher Award

Dr. Ruoxi Zhang is a highly accomplished physician and researcher in cardiovascular medicine, with over a decade of experience in clinical practice and academic research. He holds a Doctorate in Clinical Medicine from Harbin Medical University and has served in prestigious hospitals, including The Second Affiliated Hospital of Harbin Medical University and Suzhou Kowloon Hospital at Shanghai Jiao Tong University School of Medicine.

Education:

Dr. Ruoxi Zhang has a strong academic foundation in clinical and internal medicine. He earned his Doctorate in Clinical Medicine from Harbin Medical University (2013–2016) and a Master’s degree in Internal Medicine from the same institution (2007–2010). His medical journey began with a Bachelor’s degree in Clinical Medicine from Qiqihar Medical University (2002–2007). His advanced education equipped him with extensive knowledge in diagnosing and treating complex medical conditions. Through rigorous academic training and research, Dr. Zhang has developed a deep expertise in cardiovascular medicine, laying the groundwork for his distinguished career as a physician and researcher in the medical field.

Professional Experience:

Dr. Ruoxi Zhang has over a decade of experience in clinical medicine, specializing in cardiology. He began his medical career as a physician at The Second Affiliated Hospital of Harbin Medical University, where he served for ten years, gaining expertise in patient care and advanced medical procedures. He then joined Harbin Yinghua Hospital, further refining his skills in cardiovascular treatment. Currently, he is a physician at Suzhou Kowloon Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. His extensive clinical experience, combined with his research contributions, underscores his commitment to advancing cardiovascular medicine and improving patient outcomes.

Research Interests:

Dr. Ruoxi Zhang’s research interests focus on cardiovascular medicine, interventional cardiology, and advanced imaging techniques for diagnosing and treating heart diseases. He is particularly engaged in artificial intelligence applications in intracardiac echocardiography and computed tomography-derived fractional flow reserve to enhance diagnostic precision. His work explores innovative interventional strategies for patients with acute coronary syndromes, myocardial infarction, and diabetes-related cardiovascular conditions. Additionally, he investigates endothelialization processes, stent implantation techniques, and platelet aggregation in post-percutaneous coronary intervention patients. Dr. Zhang is committed to integrating novel technologies into clinical practice to improve cardiovascular outcomes and patient care.

Recognition and Impact:

Dr. Ruoxi Zhang is a distinguished physician and researcher specializing in cardiovascular medicine. As a guest editor for Frontiers in Medicine and Frontiers in Cardiovascular Medicine, he has contributed to the advancement of medical research. With numerous high-impact publications in esteemed journals, his work on artificial intelligence in echocardiography and interventional cardiology has influenced clinical practices. His research has enhanced diagnostic precision and treatment efficacy, earning recognition from the medical community. Through his dedication to innovation and patient-centered care, Dr. Zhang has established himself as a leading expert, significantly impacting the field of cardiovascular research.

Citations:

Citations – 576
h-index – 14
i10-index – 19

Conclusion:

Dr. Ruoxi Zhang’s strong academic background, extensive professional experience, editorial roles, and prolific research contributions make him a highly suitable candidate for the Best Researcher Award. His work has significantly impacted cardiovascular medicine, and his dedication to advancing medical research sets him apart as an outstanding scholar and clinician.

Top Notable Publications

Colchicine alleviates cholesterol crystal‐induced endothelial cell pyroptosis through activating AMPK/SIRT1 pathway

Author(s): M Yang, H Lv, Q Liu, L Zhang, R Zhang, X Huang, X Wang, B Han, S Hou, …

Journal: Oxidative Medicine and Cellular Longevity

Year: 2020 📅

Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow

Author(s): D Liu, H Lv, Q Liu, Y Sun, S Hou, L Zhang, M Yang, B Han, G Wang, …

Journal: Journal of Translational Medicine

Year: 2019 📰

C1q/TNF‐related protein 9 inhibits the cholesterol‐induced vascular smooth muscle cell phenotype switch and cell dysfunction by activating AMP‐dependent kinase

Author(s): Q Liu, H Zhang, J Lin, R Zhang, S Chen, W Liu, M Sun, W Du, J Hou, B Yu

Journal: Journal of Cellular and Molecular Medicine

Year: 2017 🧬

C1q/Tumor necrosis factor-related protein-3 protects macrophages against LPS-induced lipid accumulation, inflammation and phenotype transition via PPARγ and TLR4-mediated pathways

Author(s): J Lin, Q Liu, H Zhang, X Huang, R Zhang, S Chen, X Wang, B Yu, J Hou

Journal: Oncotarget

Year: 2017 💡

Identification of biomarkers for unstable angina by plasma metabolomic profiling

Author(s): M Sun, X Gao, D Zhang, C Ke, Y Hou, L Fan, R Zhang, H Liu, K Li, B Yu

Journal: Molecular BioSystems

Year: 2013 🔬

Effect of clopidogrel vs ticagrelor on platelet aggregation and inflammation markers after percutaneous coronary intervention for ST-elevation myocardial infarction

Author(s): Z Jiang, R Zhang, M Sun, Q Liu, S Wang, W Wang, Q Zhao, H Zhang, …

Journal: Canadian Journal of Cardiology

Year: 2018 💓

Relationship between fragmented QRS and NT-proBNP in patients with ST elevation myocardial infarction who underwent primary percutaneous coronary intervention

Author(s): Q Zhao, R Zhang, J Hou, B Yu

Journal: Acta Cardiologica Sinica

Year: 2018 ❤️

C1q/TNF-related protein 9 attenuates atherosclerosis by inhibiting hyperglycemia-induced endothelial cell senescence through the AMPKα/KLF4 signaling pathway

Author(s): G Wang, B Han, R Zhang, Q Liu, X Wang, X Huang, D Liu, W Qiao, …

Journal: Frontiers in Pharmacology

Year: 2021 💪

Biomarkers investigation for in-hospital death in patients with Stanford type A acute aortic dissection

Author(s): R Zhang, S Chen, H Zhang, W Wang, J Xing, Y Wang, B Yu, J Hou

Journal: International Heart Journal

Year: 2016 ❤️

Effects of methotrexate in a rabbit model of in-stent neoatherosclerosis: an optical coherence tomography study

Author(s): R Zhang, S Chen, H Zhang, Q Liu, J Xing, Q Zhao, Y Wang, B Yu, J Hou

Journal: Scientific Reports

Year: 2016 🐇

Recombinant human thioredoxin-1 protects macrophages from oxidized low-density lipoprotein-induced foam cell formation and cell apoptosis

Author(s): H Zhang, Q Liu, JL Lin, Y Wang, RX Zhang, JB Hou, B Yu

Journal: Biomolecules & Therapeutics

Year: 2018 💉

Fragmented QRS complex is a prognostic marker of microvascular reperfusion and changes in LV function occur in patients with ST elevation myocardial infarction who underwent …

Author(s): R Zhang, S Chen, Q Zhao, M Sun, B Yu, J Hou

Journal: Experimental and Therapeutic Medicine

Year: 2017 🏥

Interleukin-35 promotes early endothelialization after stent implantation by regulating macrophage activation

Author(s): X Liu, R Zhang, J Hou, J Wu, M Zhang, S Fang, X Wang, X Huang, J Tian, …

Journal: Clinical Science

Year: 2019 💉

Correlation of serum uric acid levels with nonculprit plaque instability in patients with acute coronary syndromes: a 3‐vessel optical coherence tomography study

Author(s): D Zhang, R Zhang, N Wang, L Lin, B Yu

Journal: BioMed Research International

Year: 2018 🧪

Adipose tissue-derived autotaxin causes cardiomyopathy in obese mice

Author(s): Y Xu, Y Wang, J Liu, W Cao, L Li, H Du, E Zhan, R Zhang, H Liu, M Xu, …

Journal: Journal of Molecular Endocrinology

Year: 2019 🐁

Dr. Abdirahman Ali | Interventional Cardiology | Best Researcher Award

Dr. Abdirahman Ali, Doctor of family physician, Somalia

Dr. Abdirahman Ali is a dedicated family physician from Somalia, specializing in comprehensive healthcare for individuals and families. With a strong focus on preventive medicine, patient education, and holistic treatment, Dr. Ali is committed to improving community health outcomes. His expertise spans various aspects of family medicine, ensuring personalized care and attention to diverse patient needs. Dr. Ali continues to contribute to the healthcare field in Somalia, working to advance medical practices and provide accessible healthcare solutions for all.

Profile:

Scopus Profile

Orcid profile

Education:

Dr. Abdirahman Ali holds a Master of Science in Family Medicine (2019-2022) and is currently pursuing a Master of Science in Research and Data Analysis (2022-2024), both from Amoud University in Borama, Somalia. He also earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) from the same institution in 2018. Dr. Ali combines his medical expertise with a strong focus on research and data analysis, playing a key role as a family physician and research analyst at Amoud University.

Work Experience:

Dr. Abdirahman Ali currently serves as a specialized doctor at Borama Regional Hospital, where he provides comprehensive family medicine services, achieving a 98% patient satisfaction rate. He has led significant research on the effects of climate change on community health, resulting in three peer-reviewed publications and policy changes. Additionally, Dr. Ali utilizes advanced data analysis tools, improving health outcome predictions by 20%, and collaborates with local universities and NGOs to strengthen community resilience to climate-related health challenges.

Top Notable Publications:

Prevalence and determinants of hypertension among adults in Somalia using Somalia demographic health survey data, SDHS 2020
Farih, O.A., Ali, A.O., Abokor, A.H., Egge, A.A.A., Muse, A.H.
Current Problems in Cardiology, 2024, 49(11), 102783.
DOI: [Unavailable]
Abstract: This article analyzes the prevalence and determinants of hypertension in Somali adults, utilizing the Somalia Demographic Health Survey (SDHS) data from 2020. The study identifies key factors contributing to high blood pressure in Somalia and offers policy recommendations based on the findings.

Incidental diagnosis of Brugada syndrome in a patient initially presenting with acute coronary syndrome in resource-limited settings: A case report
Said, A.I., Ali, A.O., Said, A.O., Abdillahi, M.A., Elmi, H.S.A.
Atencion Primaria Practica, 2024, 6(4), 100208.
DOI: [Unavailable]
Abstract: This case report highlights the incidental diagnosis of Brugada syndrome in a patient from a resource-limited setting, who initially presented with symptoms of acute coronary syndrome. The article emphasizes the challenges in diagnosing rare cardiac conditions in such environments.

Left temporal epilepsy unmasking tuberculoma in an immunocompetent adolescent: Case report
Said, A.I., Abdulahi, M., Ali, A.O., Walhad, S.A., Muse, A.H.
Atencion Primaria Practica, 2024, 6(2), 100198.
DOI: [Unavailable]
Abstract: This case report describes an immunocompetent adolescent diagnosed with left temporal epilepsy, which later revealed an underlying tuberculoma. The article discusses the diagnostic process and treatment approaches in resource-limited settings.

Ruoxi Zhang | Cardiology | Best Researcher Award